Faisal Khurshid Stock Analyst Profile - Leerink Partners Research Coverage - Stocknear

Faisal Khurshid

Stock Analyst at Leerink Partners

(3.88)
# 2111
Out of 5,459 analysts
24
Total ratings
Success rate
Average return
19 Stocks
Name Action PT Current % Upside Ratings Updated
STTK Shattuck Labs
Maintains: Outperform
4 2
1 100% 2 Aug 14, 2025
RYTM Rhythm Pharmaceutica...
Maintains: Outperform
88 102
102.3 -0.29% 2 Jul 10, 2025
ABCL AbCellera Biologics
Assumes: Outperform
5
4.35 14.94% 1 Jul 7, 2025
IRWD Ironwood Pharmaceuti...
Maintains: Market Perform
3 1
1.26 -20.63% 2 Apr 14, 2025
SYRE Spyre Therapeutics
Initiates Coverage On: Outperform
45
17.14 162.54% 1 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
16
9.55 67.54% 1 Mar 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
33 2
1.69 18.34% 2 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
16
5.17 209.48% 1 Feb 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
60 60
42.26 41.98% 2 Dec 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
80
91.88 -12.93% 1 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
15
2.16 594.44% 1 Nov 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
7
8 -12.5% 1 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
45
18.01 149.86% 1 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
24
32.91 -27.07% 1 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
7
1.41 396.45% 1 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
8
4.52 76.99% 1 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
5
0.85 488.24% 1 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
17 21
21.55 -2.55% 1 Mar 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
11
3.48 216.09% 1 Mar 21, 2023